Imiquimod is a prescription-grade, topical immune response modifier used to treat specific abnormal skin growths. Unlike traditional creams that attack spots directly, it works by waking up your body's own immune system to target and clear away cells causing actinic keratoses (precancerous sun spots), superficial basal cell carcinoma (a type of skin cancer), and external genital or perianal warts. Activating your local defenses helps destroy abnormal tissues and clears the path for healthy skin to grow back.
Imiquimod is an innovative, locally acting immunomodulator designed to trigger a targeted immune response inside the skin to eliminate damaged, precancerous, or virally infected cells. Under conditions of chronic sun damage or exposure to specific strains of the Human Papillomavirus (HPV), skin cells can become mutated or hijacked. This results in the formation of rough, precancerous patches (actinic keratoses), localized skin cancers (superficial basal cell carcinomas), or stubborn external warts. Because these abnormal cells often find ways to "hide" from the body's natural defenses, they can grow undisturbed. Standard freezing or burning treatments remove only the surface layers, frequently leaving underlying abnormal cells behind to trigger a recurrence.
To trigger deep, long-lasting clearance right at the cellular level, Imiquimod modifies local tissue responses directly upon application:
The active ingredient, Imiquimod, does not possess direct antiviral or anticancer activity. Instead, when rubbed into the affected skin, it acts as a potent agonist that binds directly to Toll-Like Receptor 7 (TLR7) on local immune surveillance cells. Turning on this receptor mimics a natural alarm system, tricking the skin into believing a major cellular threat is occurring. This triggers a massive, localized release of crucial immune signaling proteins, primarily interferon-alpha (IFN-alpha), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha).
This sudden flood of signaling proteins recruits a swarm of helper T-cells and killer immune cells straight to the application site. These defenses locate, attack, and systematically dismantle the abnormal, cancerous, or virally altered cells, causing them to break down. Because this process sets off a deliberate, intense immune battlefield, the treated skin will predictably become red, swollen, crusty, or raw.
Imiquimod may be indicated by your dermatologist or physician for:
Treating rough, scaly, precancerous sun spots on the face or scalp of adults with healthy immune systems.
Treating small, localized, non-melanoma skin cancers on the trunk, neck, or limbs when surgery is not an option.
Clearing up visible external warts caused by HPV on the genitals or around the anus in individuals 12 years and older.
Imiquimod may provide benefits such as:
Consult your doctor if you experience any unusual, severe, or persistent symptoms while using Imiquimod.
Imiquimod operates via a localized cell-signaling pathway that activates the innate and adaptive arms of the cutaneous immune system. The active compound, Imiquimod, is an imidazoquinoline amine derivative that functions as a selective agonist for Toll-Like Receptor 7 (TLR7). Under standard physiological conditions, TLR7 is located within the endosomal compartments of antigen-presenting cells, such as plasmacytoid dendritic cells and macrophages embedded in the epidermis.
When the cream is absorbed, it binds to TLR7, activating an intracellular signaling cascade mediated by the MyD88 adapter protein.
This pathway turns on nuclear transcription factors, inducing a robust upregulation and secretion of pro-inflammatory cytokines, specifically Interferon-alpha, Tumor Necrosis Factor-alpha, and Interleukin-12.
Stop using the cream instantly if you experience a sudden body rash, facial swelling, or severe wheezing.
It is unknown if the drug passes into human milk; consult your physician and avoid applying the cream anywhere near the breasts.
Use during pregnancy only if clearly prescribed by your doctor after a thorough evaluation of maternal and fetal safety.
This topical cream stays on the skin and does not affect your reflexes, focus, or driving abilities.
Alcohol has no direct chemical interactions with the cream, though moderation helps support overall immune health.
Safe to use, as the tiny amounts that pass through the skin are minimal and do not place processing stress on the liver.
Safe for individuals with kidney issues, as topical administration avoids systemic renal filtration pathways.
Approved for external genital warts in patients 12 and older; safety for other skin conditions has not been established in children.
Safe and widely prescribed for older adults to clear actinic keratoses caused by decades of cumulative sun exposure.
Steroids suppress the immune system and will directly turn off the immune response this cream is trying to create, stopping it from working.
Using other exfoliating treatments on the exact same spot can cause severe, deep skin irritation and raw ulcerations.
Does not interact with systemic medications because the cream works locally on the outermost layers of the skin.
If you miss a scheduled application of Imiquimod, apply the cream as soon as you remember on that day, and then continue with your regular weekly schedule. If you do not realize the mistake until the next day, skip the missed application completely and wait until your next scheduled treatment evening. Do not apply a double layer of cream or use it two days in a row to make up for a missed dose.
Therapeutic Class
Dermatological Formulations / Topical Immunomodulators and Antineoplastics
Action Class
Local Toll-Like Receptor 7 (TLR7) Agonist / Immune Response Modifier
Chemical Class
Imidazoquinoline Amine Derivative
Habit Forming
No
Checkout Editorial Policy
Imiquimod 12.5mg

₹378.2
MRP ₹461.3